Skip to main content
. 2024 Sep 18;19(9):e0300555. doi: 10.1371/journal.pone.0300555

Fig 5. Adjusted seroprevalence estimates for SARS-CoV-2 spike antibody (S-antibody) and nucleocapsid antibody (N-antibody) collected from children and adolescents aged 0–19 years undergoing anesthetic procedures between June 1 and August 31, 2022 by: a) age, b) vaccination status, c) area of remoteness Index (ARIA), d) jurisdiction, and e) socio-economic status of area of residence.

Fig 5

Footnote Fig 5: ACT: Australian Capital Territory, NSW: New South Wales, NT: Northern Territory, QLD: Queensland, SA: South Australia, TAS: Tasmania, VIC: Victoria, WA: Western Australia; SEIFA quintile: measured using the Index of Relative Socio-economic Disadvantage; Q1 –highest quintile, and Q5 –lowest quintile.